Activity Provided By:

ACHL

Keeping Up the Pace in IBD: Adaptive Learning to Optimize Therapeutic Decision-Making for Patients with UC and CD

Overview / Abstract:	Whether you’re a specialist looking for advanced-level learning around optimally managing Crohn’s disease and ulcerative colitis, a generalist needing to expand your knowledge of inflammatory bowel disease (IBD), or an allied healthcare professional wanting to support patients, don’t miss the opportunity to participate in this one-of-a-kind educational experience. In this adaptive learning activity, experience education uniquely tailored to your individual needs. Management of ulcerative colitis and Crohn’s disease is complicated due to their complex pathophysiology. As evidence continues to build and guide treatment paradigms, clinicians need to be aware of the new and emerging treatment options and skilled in the art of tailoring therapy to an individual patient’s needs, ongoing symptoms, and quality of life (QoL). In this dynamic platform, learners engage in questions across multiple topics to access insights through current data, key takeaways, and expert guidance, in order to optimize treatment of these chronic autoimmune disorders.
Expiration	Aug 29, 2023
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Online, Webinar / Webcast / Video
Credits / Hours	3.00 AMA PRA Category 1 Credit(s)™
Accreditation	ACCME,
Presenters / Authors / Faculty	Benjamin Cohen, MD Co-Section Head and Clinical Director for Inflammatory Bowel Disease Cleveland Clinic Foundation Cleveland, OH Neilanjan Nandi, MD Associate Professor of Clinical Medicine Department of Medicine, Division of Gastroenterology & Hepatology University of Pennsylvania Philadelphia, PA
Sponsors / Supporters / Grant Providers	Sponsored by the Academy for Continued Healthcare Learning (ACHL). Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Keywords / Search Terms	ACHL CME, CE, adaptive learning, adaptive, AdaptED, Takeda, Neilanjan Nandi, Benjamin Cohen, Ulcerative Colitis, UC, Crohn’s Disease, Crohn’s, CD, IBD, QOL, treatment, goals, T2T, treat-to-target, disparities, diagnosis, Disease Monitoring, infliximab, adalimumab, immunomodulator, STRIDE-II, stricturing, SEAVUE, ustekinumab, SERENE, HIR, SIR, DINE-CD, Risankizumab, ADVANCE, MOTIVATE, Rutgeert’s score, upadacitinib, anti-TNF, SDM Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map